vs

Side-by-side financial comparison of LEAR CORP (LEA) and Labcorp (LH). Click either name above to swap in a different company.

LEAR CORP is the larger business by last-quarter revenue ($6.0B vs $3.5B, roughly 1.7× Labcorp). Labcorp runs the higher net margin — 7.9% vs 1.4%, a 6.5% gap on every dollar of revenue. On growth, Labcorp posted the faster year-over-year revenue change (5.8% vs 4.8%). LEAR CORP produced more free cash flow last quarter ($281.1M vs $70.5M). Over the past eight quarters, Labcorp's revenue compounded faster (4.8% CAGR vs -0.1%).

Lear Corporation is an American company that manufactures automotive seating and electrical systems. In 2019, it ranked #147 and in 2018, it ranked #148 on the Fortune 500 list.

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

LEA vs LH — Head-to-Head

Bigger by revenue
LEA
LEA
1.7× larger
LEA
$6.0B
$3.5B
LH
Growing faster (revenue YoY)
LH
LH
+1.0% gap
LH
5.8%
4.8%
LEA
Higher net margin
LH
LH
6.5% more per $
LH
7.9%
1.4%
LEA
More free cash flow
LEA
LEA
$210.6M more FCF
LEA
$281.1M
$70.5M
LH
Faster 2-yr revenue CAGR
LH
LH
Annualised
LH
4.8%
-0.1%
LEA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LEA
LEA
LH
LH
Revenue
$6.0B
$3.5B
Net Profit
$82.7M
$277.8M
Gross Margin
5.7%
28.7%
Operating Margin
2.6%
10.8%
Net Margin
1.4%
7.9%
Revenue YoY
4.8%
5.8%
Net Profit YoY
-6.1%
30.5%
EPS (diluted)
$1.58
$3.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEA
LEA
LH
LH
Q1 26
$3.5B
Q4 25
$6.0B
$3.5B
Q3 25
$5.7B
$3.6B
Q2 25
$6.0B
$3.5B
Q1 25
$5.6B
$3.3B
Q4 24
$5.7B
$3.3B
Q3 24
$5.6B
$3.3B
Q2 24
$6.0B
$3.2B
Net Profit
LEA
LEA
LH
LH
Q1 26
$277.8M
Q4 25
$82.7M
$164.7M
Q3 25
$108.2M
$261.1M
Q2 25
$165.2M
$237.9M
Q1 25
$80.7M
$212.8M
Q4 24
$88.1M
$143.4M
Q3 24
$135.8M
$169.3M
Q2 24
$173.1M
$205.3M
Gross Margin
LEA
LEA
LH
LH
Q1 26
28.7%
Q4 25
5.7%
28.2%
Q3 25
6.4%
28.8%
Q2 25
7.3%
29.7%
Q1 25
6.5%
28.3%
Q4 24
6.8%
26.9%
Q3 24
7.3%
27.6%
Q2 24
7.5%
28.8%
Operating Margin
LEA
LEA
LH
LH
Q1 26
10.8%
Q4 25
2.6%
7.6%
Q3 25
3.4%
11.1%
Q2 25
4.1%
11.2%
Q1 25
3.3%
9.7%
Q4 24
3.7%
6.5%
Q3 24
3.9%
7.7%
Q2 24
4.3%
9.2%
Net Margin
LEA
LEA
LH
LH
Q1 26
7.9%
Q4 25
1.4%
4.7%
Q3 25
1.9%
7.3%
Q2 25
2.7%
6.7%
Q1 25
1.5%
6.4%
Q4 24
1.5%
4.3%
Q3 24
2.4%
5.2%
Q2 24
2.9%
6.4%
EPS (diluted)
LEA
LEA
LH
LH
Q1 26
$3.35
Q4 25
$1.58
$1.98
Q3 25
$2.02
$3.12
Q2 25
$3.06
$2.84
Q1 25
$1.49
$2.52
Q4 24
$1.64
$1.72
Q3 24
$2.41
$2.00
Q2 24
$3.02
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEA
LEA
LH
LH
Cash + ST InvestmentsLiquidity on hand
$1.0B
$981.1M
Total DebtLower is stronger
$2.7B
$5.8B
Stockholders' EquityBook value
$5.0B
$8.7B
Total Assets
$14.8B
$19.1B
Debt / EquityLower = less leverage
0.54×
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEA
LEA
LH
LH
Q1 26
$981.1M
Q4 25
$1.0B
$532.3M
Q3 25
$1.0B
$598.1M
Q2 25
$887.9M
$647.3M
Q1 25
$779.9M
$369.4M
Q4 24
$1.1B
$1.5B
Q3 24
$763.9M
$1.5B
Q2 24
$950.3M
$265.1M
Total Debt
LEA
LEA
LH
LH
Q1 26
$5.8B
Q4 25
$2.7B
Q3 25
$2.8B
Q2 25
$2.8B
Q1 25
$2.7B
Q4 24
$2.7B
Q3 24
$2.8B
Q2 24
$2.7B
Stockholders' Equity
LEA
LEA
LH
LH
Q1 26
$8.7B
Q4 25
$5.0B
$8.6B
Q3 25
$5.1B
$8.7B
Q2 25
$5.1B
$8.5B
Q1 25
$4.7B
$8.3B
Q4 24
$4.5B
$8.1B
Q3 24
$4.8B
$8.2B
Q2 24
$4.8B
$8.0B
Total Assets
LEA
LEA
LH
LH
Q1 26
$19.1B
Q4 25
$14.8B
$18.4B
Q3 25
$15.2B
$18.3B
Q2 25
$15.3B
$18.1B
Q1 25
$14.6B
$17.6B
Q4 24
$14.0B
$18.4B
Q3 24
$14.8B
$18.6B
Q2 24
$14.7B
$16.7B
Debt / Equity
LEA
LEA
LH
LH
Q1 26
0.67×
Q4 25
0.54×
Q3 25
0.54×
Q2 25
0.54×
Q1 25
0.59×
Q4 24
0.61×
Q3 24
0.58×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEA
LEA
LH
LH
Operating Cash FlowLast quarter
$475.9M
$191.5M
Free Cash FlowOCF − Capex
$281.1M
$70.5M
FCF MarginFCF / Revenue
4.7%
2.0%
Capex IntensityCapex / Revenue
3.3%
3.4%
Cash ConversionOCF / Net Profit
5.75×
0.69×
TTM Free Cash FlowTrailing 4 quarters
$527.2M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEA
LEA
LH
LH
Q1 26
$191.5M
Q4 25
$475.9M
$614.2M
Q3 25
$444.4M
$387.2M
Q2 25
$296.2M
$620.6M
Q1 25
$-127.7M
$18.5M
Q4 24
$680.8M
$777.2M
Q3 24
$182.7M
$277.3M
Q2 24
$291.2M
$561.1M
Free Cash Flow
LEA
LEA
LH
LH
Q1 26
$70.5M
Q4 25
$281.1M
$490.3M
Q3 25
$307.0M
$280.5M
Q2 25
$170.8M
$542.7M
Q1 25
$-231.7M
$-107.5M
Q4 24
$488.7M
$665.1M
Q3 24
$50.5M
$161.5M
Q2 24
$170.4M
$432.9M
FCF Margin
LEA
LEA
LH
LH
Q1 26
2.0%
Q4 25
4.7%
13.9%
Q3 25
5.4%
7.9%
Q2 25
2.8%
15.4%
Q1 25
-4.2%
-3.2%
Q4 24
8.6%
20.0%
Q3 24
0.9%
4.9%
Q2 24
2.8%
13.4%
Capex Intensity
LEA
LEA
LH
LH
Q1 26
3.4%
Q4 25
3.3%
3.5%
Q3 25
2.4%
3.0%
Q2 25
2.1%
2.2%
Q1 25
1.9%
3.8%
Q4 24
3.4%
3.4%
Q3 24
2.4%
3.5%
Q2 24
2.0%
4.0%
Cash Conversion
LEA
LEA
LH
LH
Q1 26
0.69×
Q4 25
5.75×
3.73×
Q3 25
4.11×
1.48×
Q2 25
1.79×
2.61×
Q1 25
-1.58×
0.09×
Q4 24
7.73×
5.42×
Q3 24
1.35×
1.64×
Q2 24
1.68×
2.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEA
LEA

Other$3.5B59%
Seating Segment$1.9B32%
E Systems Segment$520.6M9%

LH
LH

Revenues$2.8B78%
Other$775.5M22%

Related Comparisons